Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting

First Affiliated Hospital of Zhejiang University · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
carcinomareal-world-evidence
carcinoma, non-small-cell lung, epidermal growth factor receptor mutation, osimertinib, real world evidence, non-interventional, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 911634
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.